← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #88 OF 1,000 MOST-CITED

Written procedures - product complaint

FDA cited this observation 253 times across 230 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods253
BY FISCAL YEAR
FY202422
FY202330
FY202233
FY202124
FY202021
FY201937
FY201843
FY201743

How FDA worded it — real examples

You did not establish written procedures for the requirements to review and investigate a product complaint.

Evol Nutrition Associates, Inc. · Marietta, Georgia · Foods · 2024-07-09

You did not establish written procedures for the requirements to review and investigate a product complaint.

R. Day Enterprises, Inc. · Upland, California · Foods · 2024-06-14

You did not establish written procedures for the requirements to review and investigate a product complaint.

I AM WELL HOLISTIC INC · Cleveland, Ohio · Foods · 2024-05-28

You did not establish and follow written procedures for the requirements to review and investigate a product complaint.

World Green Nutrition Inc. · San Antonio, Texas · Foods · 2024-05-09

You did not establish written procedures for the requirements to review and investigate a product complaint.

VBS Distribution, Inc · Westminster, California · Foods · 2024-04-18

You did not establish written procedures for the requirements to review and investigate a product complaint.

MacuHealth Distribution, Inc. · Phoenix, Arizona · Foods · 2024-04-16

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Quality risk managementPharmaceutical quality systemFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →